Classification Term: 3227

Tetralins (ontology term: CHEMONTID:0000048)

Polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane." [Wikipedia:Tetralins]

found 62 associated metabolites at class metabolite taxonomy ontology rank level.

Ancestor: Benzenoids

Child Taxonomies: Tametralines

Dezocine

5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13S*)

C16H23NO (245.17795479999998)


Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

tetrahydrozoline

4,5-Dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole

C13H16N2 (200.13134159999998)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].

   

5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin

7-(dipropylamino)-4-fluoro-5,6,7,8-tetrahydronaphthalen-1-ol

C16H24FNO (265.1841826)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

Tamibarotene

4-((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl)benzoic acid

C22H25NO3 (351.18343400000003)


Tamibarotene is only found in individuals that have used or taken this drug. It is a novel synthetic retinoid for acute promyelocytic leukaemia (APL). Tamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.Tamibarotene is a specific agonist for retinoic acid receptor alpha/beta with possible binding to retinoid X receptors (RXR). C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent Same as: D01418

   

1,2,3,4-Tetrahydronaphthalene

Naphthalene 1,2,3,4-tetrahydride

C10H12 (132.0938952)


   

1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene

1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene

C10H10O3 (178.062991)


1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene is considered to be soluble (in water) and relatively neutral

   

Levobunolol

(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone

C17H25NO3 (291.18343400000003)


Levobunolol is only found in individuals that have used or taken this drug. It is a nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. [PubChem]Levobunolols mechanism of action in reducing IOP is not clearly defined, but is believed to be due to a reduction of the production of aqueous humor via blockage of endogenous catecholamine-stimulated increases in cyclic adenosine monophosphate (AMP) concentrations within the ciliary processes. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

   

6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic acid

C24H29NO2 (363.2198174)


   

Nadolol

(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol

C17H27NO4 (309.1939982)


Nadolol is only found in individuals that have used or taken this drug. It is a non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for migraine disorders and for tremor. [PubChem]Like other beta-adrenergic antagonists, nadolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, nadolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, nadolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Nadolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Nadolol (SQ-11725) is a non-selective and orally active β-adrenergic receptors blocker and is a substrate of organic anion transporting polypeptide 1A2 (OATP1A2). Nadolol has the the potential for high blood pressure, angina pectoris and vascular headaches research[1][2][3].

   

norsertraline

Cis-(+/-)-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

C16H15Cl2N (291.058149)


norsertraline is a metabolite of sertraline. Sertraline hydrochloride (trademark names Zoloft and Lustral) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It was introduced to the market by Pfizer in 1991. Sertraline is primarily used to treat major depression in adult outpatients as well as obsessive–compulsive, panic, and social anxiety disorders in both adults and children. In 2007, it was the most prescribed antidepressant on the U.S. retail market, with 29,652,000 prescriptions. (Wikipedia) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3623

   

(S)-11,12,13-Trinor-7-calamenone

4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-one

C12H14O (174.1044594)


xi-11,12,13-Trinor-7-calamenone is found in root vegetables. xi-11,12,13-Trinor-7-calamenone is a constituent of Cyperus rotundus (nutgrass). Constituent of Cyperus rotundus (nutgrass). xi-11,12,13-Trinor-7-calamenone is found in root vegetables.

   

1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-7-methoxy-2,6-naphthalenediol

1-[(2Z)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-yl]-7-methoxy-1,2,3,4-tetrahydronaphthalene-2,6-diol

C20H22O5 (342.1467162)


1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-7-methoxy-2,6-naphthalenediol is found in fruits. 1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-7-methoxy-2,6-naphthalenediol is isolated from the rhizomes of Musa acuminata (dwarf banana) infected with Fusarium oxysporum. Isolated from the rhizomes of Musa acuminata (dwarf banana) infected with Fusarium oxysporum. 1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-7-methoxy-2,6-naphthalenediol is found in fruits.

   

Rishitinol

(2R,3S)-rel-(+)-1,2,3,4-Tetrahydro-3-hydroxy-alpha,alpha,5,8-tetramethyl-2-naphthalenemethanol

C15H22O2 (234.1619712)


Phytoalexin of tubers of white potatoes (Solanum tuberosum and Solanum demissum) infected by Phytophthora infestans. Rishitinol is found in alcoholic beverages and potato. Rishitinol is found in alcoholic beverages. Phytoalexin of tubers of white potatoes (Solanum tuberosum and Solanum demissum) infected by Phytophthora infestans.

   

Flavidulol B

7-Ethenyl-5,6,7,8-tetrahydro-4-methoxy-7-methyl-6-(1-methylethenyl)-1-naphthalenol, 9ci

C17H22O2 (258.1619712)


Flavidulol B is found in mushrooms. Flavidulol B is isolated from the edible but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Isolated from the edible but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Flavidulol B is found in mushrooms.

   

(S)-Isosclerone

(4S)-4,8-Dihydroxy-3,4-dihydronaphthalene-1(2H)-one

C10H10O3 (178.062991)


(S)-Isosclerone is found in nuts. (S)-Isosclerone is a constituent of Juglans regia (walnut). Constituent of Juglans regia (walnut). (S)-Isosclerone is found in nuts.

   

1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-6,7-dimethoxy-2-naphthalenol

1-[(2Z)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-yl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-ol

C21H24O5 (356.1623654)


1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-6,7-dimethoxy-2-naphthalenol is found in fruits. 1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-6,7-dimethoxy-2-naphthalenol is from Musa acuminata (dwarf banana) infected with Fusarium oxysporum. From Musa acuminata (dwarf banana) infected with Fusarium oxysporum. 1,2,3,4-Tetrahydro-1-[1-hydroxy-3-(4-hydroxyphenyl)-2-propenyl]-6,7-dimethoxy-2-naphthalenol is found in fruits.

   

10,11-Epidioxycalamene

4,8,11,11-tetramethyl-9,10-dioxatricyclo[6.3.2.0²,⁷]trideca-2,4,6-triene

C15H20O2 (232.14632200000003)


10,11-Epidioxycalamene is found in root vegetables. 10,11-Epidioxycalamene is a constituent of Cyperus rotundus (nutgrass). Constituent of Cyperus rotundus (nutgrass). 10,11-Epidioxycalamene is found in root vegetables.

   

(R)-Shinanolone

4,8-dihydroxy-6-methyl-1,2,3,4-tetrahydronaphthalen-1-one

C11H12O3 (192.0786402)


(R)-Shinanolone is found in fruits. (R)-Shinanolone is isolated from Diospyros kaki (Japanese persimmon

   

alpha-Ionene

1,1,6-trimethyl-1,2,3,4-tetrahydronaphthalene

C13H18 (174.1408428)


Alpha-ionene, also known as α-ionene, is a member of the class of compounds known as tetralins. Tetralins are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane. Alpha-ionene can be found in carrot and wild carrot, which makes alpha-ionene a potential biomarker for the consumption of these food products. alpha-Ionene belongs to the family of Tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane.

   

Rotigotine

6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.165676)


Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. Rotigotine was developed by Aderis Pharmaceuticals. In 1998, Aderis licensed worldwide development and commercialization rights for rotigotine to the German pharmaceutical company Schwarz Pharma (today a subsidiary of the Belgian company UCB S.A.). The drug has been approved by the EMEA for use in Europe in 2006 and is today being sold in several European countries. In 2007, the Neupro patch was approved by the Food and Drug Administration (FDA) as the first transdermal treatment of Parkinsons disease in the United States. However, as of 2008, Schwarz Pharma has recalled all Neupro patches in the United States and some in Europe because of problems with the delivery mechanism. Rotigotine has been authorized as a treatment for RLS since August 2008. D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

1,2,3,4,Tetrahydro-1,5,7-trimethylnapthalene

1,5,7-trimethyl-1,2,3,4-tetrahydronaphthalene

C13H18 (174.1408428)


1,2,3,4,tetrahydro-1,5,7-trimethylnapthalene belongs to the family of Tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane.

   

N-Despropyl-rotigotine

6-{[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C16H19NOS (273.1187284)


N-Despropyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)

   

N-Desthienylethyl-rotigotine

6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

C13H19NO (205.14665639999998)


N-Desthienylethyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)

   

2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene

1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one

C18H26O (258.1983546)


2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene belongs to the class of organic compounds known as tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane. Flavouring compound [Superscent]

   

(2E,4E)-5-[2-Methyl-2-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene-6-yl)cyclopropyl]-3-methyl-2,4-pentadienoic acid

(2E,4E)-5-[2-Methyl-2-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene-6-yl)cyclopropyl]-3-methyl-2,4-pentadienoic acid

C24H32O2 (352.24021719999996)


   

1,2,3,4-Tetrahydro-1-naphthylamine

1,2,3,4-tetrahydronaphthalen-1-amine

C10H13N (147.1047938)


   

1,2,3,4-Tetrahydro-2-naphthylamine

2-Aminotetralin hydrochloride, (+-)-isomer

C10H13N (147.1047938)


   

N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid

N-hydroxy-N-[3-(5,6,7,8-tetrahydronaphthalen-2-yl)prop-2-en-1-yl]acetamide

C15H19NO2 (245.1415714)


   

6-(Dipropylamino)-5,6,7,8-tetrahydronaphthalene-1,2-diol

2-(N,N-Dipropyl)amino-5,6-dihydroxytetralin, hydrochloride, (+-)-isomer

C16H25NO2 (263.188519)


   

5,6-Dihydroxy-2-methylaminotetralin

6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2-diol

C11H15NO2 (193.110273)


   

4-P-Pdot

N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanimidate

C19H21NO (279.1623056)


   

5-OH-Dpat

5-Hydroxy-2-N,N-dipropylaminotetralin hydrochloride, (+-)-isomer

C16H25NO (247.193604)


   

4-(1-Cyanoethyl)-1,2,3,4-tetrahydronaphthalene-1-carbonitrile

4-(1-Cyanoethyl)-1,2,3,4-tetrahydronaphthalene-1-carbonitrile

C14H14N2 (210.1156924)


   

6,7-Dihydroxy-2-dimethylaminotetralin

2,3-Naphthalenediol,6-(dimethylamino)-5,6,7,8-tetrahydro-(9CI)

C12H17NO2 (207.12592220000002)


   

7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol

7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol

C16H25NO (247.193604)


   

8-OH-Dpat

7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

C16H25NO (247.193604)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists 8-OH-DPAT is a potent and selective 5-HT agonist, with a pIC50 of 8.19 for 5-HT1A and a Ki of 466 nM for 5-HT7; 8-OH-DPAT weakly binds to 5-HT1B (pIC50, 5.42), 5-HT (pIC50 <5).

   

Retinoid 9CUAB30

3,7-Dimethyl-8-(1,2,3,4-tetrahydro-1-naphthalenyliden)-(2E,4E,6E)-2,4,6-octatrienoate

C20H22O2 (294.1619712)


   

N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide

N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulphonamide

C14H19N3O3S (309.11470640000005)


   

6,7-Dihydroxy-2-aminotetralin

2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene

C10H13NO2 (179.09462380000002)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

alpha-Neoendorphin

6-Amino-2-({[1-(2-{[6-amino-2-({2-[(2-{[2-({2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxyethylidene}amino)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-5-carbamimidamido-1-hydroxypentylidene}amino)-1-hydroxyhexylidene]amino}-3-(4-hydroxyphenyl)propanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)hexanoate

C60H89N15O13 (1227.6763944)


   

1-Tetralone

1,2,3,4-tetrahydronaphthalen-1-one

C10H10O (146.073161)


   

Solgol

5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol

C17H27NO4 (309.1939982)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Nadolol (SQ-11725) is a non-selective and orally active β-adrenergic receptors blocker and is a substrate of organic anion transporting polypeptide 1A2 (OATP1A2). Nadolol has the the potential for high blood pressure, angina pectoris and vascular headaches research[1][2][3].

   

(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin

N,N-dimethyl-5-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine

C18H25N3 (283.204837)


   

Bedoradrine

2-[[7-[[2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N,N-dimethylacetamide

C24H32N2O5 (428.2311102)


   

N-[1'-(6-Cyano-1,2,3,4-tetrahydronaphthalen-2-yl)-4-hydroxyspiro[3,4-dihydrochromene-2,4'-piperidine]-6-yl]methanesulfonamide

N-[1-(6-Cyano-1,2,3,4-tetrahydronaphthalen-2-yl)-4-hydroxy-3,4-dihydrospiro[1-benzopyran-2,4-piperidine]-6-yl]methanesulphonamide

C25H29N3O4S (467.1878674000001)


   

EMycin E

7-hydroxy-8-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)-3-methyl-1,2,3,4-tetrahydronaphthalen-1-one

C19H18O4 (310.1205028)


   

Eptazocine

1,11-dimethyl-11-azatricyclo[7.4.1.0^{2,7}]tetradeca-2(7),3,5-trien-4-ol

C15H21NO (231.1623056)


   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)-1,2,3,4-tetrahydronaphthalen-1-one

C19H21NO2 (295.1572206)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Irene

1,1,2,6-tetramethyl-1,2,3,4-tetrahydronaphthalene

C14H20 (188.15649200000001)


   

6-[1-(3,5,5,8,8-Pentamethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

C24H29NO2 (363.2198174)


   

Mibefradil

2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetic acid

C29H38FN3O3 (495.289705)


   

Naxagolide

4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol

C15H21NO2 (247.15722060000002)


   

Nepicastat

5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-2,3-dihydro-1H-imidazole-2-thione

C14H15F2N3S (295.0954694)


   

Nolomirole

6-(Methylamino)-2-[(2-methylpropanoyl)oxy]-5,6,7,8-tetrahydronaphthalen-1-yl 2-methylpropanoic acid

C19H27NO4 (333.1939982)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

r-(+)-8-hydroxydipropylaminotetralin

8-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

C16H25NO (247.193604)


   

3-Propyl-3a,4,5,9b-tetrahydro-2H-benzo[g][1,3]benzoxazole

3-Propyl-3a,4,5,9b-tetrahydro-2H-benzo[g][1,3]benzoxazole

C14H19NO (217.14665639999998)


   

4-(4-Aminophenyl)-5,6,7,8-tetrahydronaphthalen-1-amine

4-(4-Aminophenyl)-5,6,7,8-tetrahydronaphthalen-1-amine

C16H18N2 (238.1469908)


   

Terutroban

3-[6-(4-Chlorobenzenesulphonamido)-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl]propanoic acid

C20H22ClNO4S (407.0958002000001)


   

Versalide

1-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one

C18H26O (258.1983546)


Flavouring compound [Superscent]

   

6-(Dipropylamino)-5,6,7,8-tetrahydronaphthalene-2,3-diol

6-(Dipropylamino)-5,6,7,8-tetrahydronaphthalene-2,3-diol

C16H25NO2 (263.188519)